EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sequence-Engineered Recombinant Human Collagen as a Biomacromolecular Platform for Guided Bone Regeneration Membranes

Jianing Hou, Zhuoyue Chen, Meihua Wang, Zhen Tian, Fulin Chen, Yuan Li, Xue Feng

Biomolecules · 26.10.2026 · 16 (11) · 1561

DOI: 10.3390/biom16111561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 26.10.2026. Verfasst von Jianing Hou und 6 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Effective repair of bone defects remains a major clinical challenge. Guided bone regeneration (GBR) membranes promote bone regeneration by preventing soft-tissue invasion; however, synthetic membranes often exhibit limited bioactivity, whereas animal-derived collagen membranes face concerns related to source safety, immunogenicity, and batch variability. Here, we developed a sequence-engineered recombinant human collagen (rhCol)-based biomaterial platform and fabricated a degradable bilayer membrane (rhColM) through dehydrothermal treatment free of exogenous chemical crosslinkers. rhColM exhibited a tensile strength of 5.44 MPa, a porosity of 76.26%, and an asymmetric architecture consisting of a dense barrier layer and a porous bone-facing layer. In rat subcutaneous implantation, rhColM showed favorable biocompatibility without obvious inflammatory cell infiltration or connective tissue penetration at 1 and 3 weeks. In a rabbit lateral femoral condyle defect model, rhColM increased bone volume fraction to 42.54%, 90.70% and 99.41% at 4, 8 and 12 weeks, respectively, compared with 36.19%, 76.36% and 90.15% in controls. Histological analysis revealed progressive bone formation along the rhColM interface and substantial defect repair with lamellar bone-like tissue by 8 weeks, while rhColM was no longer visibly detected. These findings highlight sequence-engineered rhCol as a promising and source-defined biomacromolecular platform for developing recombinant collagen-based GBR membranes.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Hou, J., Chen, Z., Wang, M., Tian, Z., Chen, F., Li, Y., & Feng, X. (2026). Sequence-Engineered Recombinant Human Collagen as a Biomacromolecular Platform for Guided Bone Regeneration Membranes. Biomolecules, 16(11), 1561. https://doi.org/10.3390/biom16111561

Vancouver

Hou J, Chen Z, Wang M, Tian Z, Chen F, Li Y, et al. Sequence-Engineered Recombinant Human Collagen as a Biomacromolecular Platform for Guided Bone Regeneration Membranes. Biomolecules. 2026;16(11):1561. doi:10.3390/biom16111561

BibTeX
@article{Hou2026,
  author = {Hou, Jianing and Chen, Zhuoyue and Wang, Meihua and Tian, Zhen and Chen, Fulin and Li, Yuan and Feng, Xue},
  title = {Sequence-Engineered Recombinant Human Collagen as a Biomacromolecular Platform for Guided Bone Regeneration Membranes},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1561},
  doi = {10.3390/biom16111561}
}
Kostenlos starten →